Thursday, September 21, 2017 10:15 PM ET
Insider Selling in FibroGen (FGEN) Shares Continues
One insider — Thomas B Neff, Director and Officer — today, sold 38,636 shares of FibroGen having a market value of approximately $2,065,485, as disclosed in a form 4 document filed with the SEC. There have been 5 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been sales resulting in the sale of 87,838 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 126,474 shares and have averaged 21,079 shares per transaction over this time period.
Over the last 90 days, the number of insider buy/sell trades at FibroGen is greater than its 182-company peer group average. The Biotechnology & Medical Research peer group saw 215 buy/sell trades during this period for an average of 1.2 transactions per company. However, the number of shares traded per transaction by FibroGen insiders is lower than its peers. Within the peer group there were 8,576,547 shares purchased and 36,892,906 shares sold with company insiders selling 131,704 shares on average over this time period.
The data used in creating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.